CamNTF is a forum for all scientists interested in research and development of novel therapeutics in Cambridge and the local area, including scientists at the university, Addenbrooke’s hospital, pharmaceutical companies, biotechs, CROs and not-for-profit organisations.

Watch this video to hear highlights from the 2021 event, including:

• Professor Daniel Longely, Queen’s University Belfast, discussing first-in-class inhibitors of the major cell death regulator, FLIP, a programme since out-licenced to Ipsen
• Professor Laurence Pearl, University of Sussex, explaining phosphorylation-dependent assembly of the DNA damage response
• Dr Eddy Littler, COO of ReViral Ltd, presenting the development of medicines for respiratory virus infections (flu and RSV) and the lessons learnt from SARS-CoV-2. ReViral has since been acquired by Pfizer.

Watch now